Explore more publications!
Health Times Virgin Islands
Got News to Share?

Health Times Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times Virgin Islands.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on November 17, 2025

Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
Nov. 17, 2025

Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder

Indeterminate GlobeNewswire
Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash
Nov. 17, 2025

Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash

Indeterminate GlobeNewswire
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)
Nov. 17, 2025

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)

Indeterminate GlobeNewswire
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Nov. 17, 2025

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Eviden-built JUPITER Supercomputer Hits Exascale Milestone According to the TOP500, a First in Europe
Nov. 17, 2025

Eviden-built JUPITER Supercomputer Hits Exascale Milestone According to the TOP500, a First in Europe

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
Nov. 17, 2025

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Nov. 17, 2025

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
Nov. 17, 2025

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference

Indeterminate GlobeNewswire
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
Nov. 17, 2025

Candel Therapeutics to Host Virtual R&D Event on December 5, 2025

Indeterminate GlobeNewswire
Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow
Nov. 17, 2025

Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow

Indeterminate GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov. 17, 2025

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
Nov. 17, 2025

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Nov. 17, 2025

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

Indeterminate GlobeNewswire
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results
Nov. 17, 2025

Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results

Indeterminate GlobeNewswire
Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products
Nov. 17, 2025

Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products

Indeterminate GlobeNewswire
LifeMD Reports Third Quarter 2025 Results
Nov. 17, 2025

LifeMD Reports Third Quarter 2025 Results

Indeterminate GlobeNewswire
Invivyd Announces Proposed Public Offering of Common Stock
Nov. 17, 2025

Invivyd Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics
Nov. 17, 2025

Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand
Nov. 17, 2025

Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand

Indeterminate GlobeNewswire
Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation
Nov. 17, 2025

Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions